|By PR Newswire||
|April 21, 2014 10:34 AM EDT||
KENNEDY SPACE CENTER, Fla., April 21, 2014 /PRNewswire-USNewswire/ -- The Center for the Advancement of Science in Space (CASIS) is proud to announce its research payloads berthed with the International Space Station (ISS) on Sunday, April 20. Space Exploration Technologies Corporation's (SpaceX) Dragon capsule successfully berthed with the ISS, marking the completion of its launch to resupply the ISS with cargo and research. CASIS is tasked with managing and promoting research onboard the ISS U.S. National Laboratory.
Research onboard the SpaceX Dragon capsule included a range of experiments from life sciences. This is the second mission that has been responsible for launching CASIS-sponsored investigations to the ISS. In January, Orbital Sciences Corporation's Cygnus capsule sent the first CASIS-sponsored investigations to the ISS. Below is an overview of the major payloads now onboard the ISS sponsored by CASIS:
Crystalline Monoclonal Antibody
Paul Reichert, Merck Research Laboratories
Commercial investigator Merck will focus on the protein crystal growth of a human monoclonal antibody developed by its research labs that is currently undergoing clinical trials for treatment of an immunological disease. High quality crystalline suspensions of the antibodies in microgravity will aid in not only structure determination but also pharmaceutical applications, such as drug delivery and purification/storage of the therapeutic substance.
IPPase Crystal Growth in Microgravity
Dr. Joseph Ng, iXpressGenes, Inc.
This investigation will produce protein crystals large enough for a specific type of crystallography that can show very intricate details of protein structure. The specific enzyme being studied is involved in a variety of cell functions, including protein production — but a very detailed part of how this enzyme works is unknown. Producing crystals that allow analysis of very small and detailed structural features will not only help researchers understand this protein's function but also determine best practices for studies of other proteins at this level of detail.
Crystallization of Medically Relevant Proteins Using Microgravity
Dr. Sergey Korolev, St. Louis Medical Center
Research on this investigation focuses on improving crystals of two medically important proteins. These two proteins have multiple functions within cells, and results could therefore assist in the development of various medical interventions, from anticoagulant therapies to drug treatments for cardiovascular disease, diabetes, muscular dystrophy and Parkinson's disease.
Exploiting On-Orbit Crystal Properties for Structural Studies of Medically and Economically Important Targets
Dr. Edward Snell, SUNY Buffalo
This research focuses on growing crystals of four proteins associated with human disease. These proteins crystallize on Earth but not with sufficient quality and uniformity to determine their structures. Larger, better-organized crystals of these specific proteins could have a significant impact on drug development for Parkinson's disease, bovine spongiform encephalopathy, ethylmalonic aciduri and cutaneous squamous cell carcinoma.
Crystallization of Huntingtin Exon 1 Using Microgravity
Dr. Pamela Bjorkman, California Institute of Technology
This research focuses huntingtin, the protein responsible for Huntington's disease. The structure of this protein remains unknown. Procuring a high-resolution structure would have significant scientific and medical impact in understanding the structural basis for neural toxicity and developing treatments for Huntington's disease and other related disorders, such as spinocerebellar ataxia.
Crystallization of Human Membrane ABC Proteins in Microgravity
Dr. Stephen Aller, University of Alabama-Birmingham
This investigation focuses on determining the structure of human membrane proteins, which could accelerate the commercialization of next-generation drugs to treat AIDS-related dementia, high cholesterol, atherosclerosis, cystic fibrosis and multi-drug resistance as it relates to cancer.
Molecular Biology of Plant Development in the Spaceflight Environment
Dr. Anna-Lisa Paul, University of Florida
This research focuses on the growth and development of Arabidopsis thaliana seedlings in the spaceflight environment. Researchers seek to identify the genes involved in plant root morphology and adaptive physiology; specifically, how a root knows in which direction to grow when gravity is absent. Results will expand on previous ISS research in this area and inform the study of specific molecular pathways involved in plant adaptive physiology on Earth.
Many of the experiments delivered by the SpaceX Dragon capsule come from the first CASIS-sponsored RFP, "Advancing Protein Crystallization in Microgravity." CASIS believes that through this research, potential therapies can be developed and a baseline for future protein crystal growth experimentation will be established. Additionally, a joint project from NASA, CASIS and the National Institute of Health is onboard, "T-Cell Activation in Aging," in which Dr. Millie Hughes-Fulford will attempt to better understand and develop treatments for disorders of immune suppression by discovering the molecular basis of T-cell suppression in spaceflight.
"Today signifies yet another historic moment for CASIS and our launch partner, SpaceX," said President and Executive Director Gregory H. Johnson. "The research that is now on the ISS has the potential to unlock secrets that could create therapies to improve human health and performance. Additionally, this launch culminates our first official increment period of Advancing Research Knowledge 1. This initial launch period has been instrumental in the further development of CASIS and we look forward to sending additional exciting and innovative research capable of enhancing science in space, for life on Earth."
To learn more about the research destined for the ISS during the first official launch increment period for CASIS, Advancing Research Knowledge 1 (ARK1), please visit: ark1.iss-casis.org
About CASIS: The Center for the Advancement of Science in Space (CASIS) was selected by NASA in July 2011 to maximize use of the International Space Station (ISS) U.S. National Laboratory through 2020. CASIS is dedicated to supporting and accelerating innovations and new discoveries that will enhance the health and wellbeing of people and our planet. For more information, visit www.iss-casis.org.
About the ISS National Laboratory: In 2005, Congress designated the U.S. portion of the International Space Station as the nation's newest national laboratory to maximize its use for improving life on Earth, promoting collaboration among diverse users, and advancing STEM education. This unique laboratory environment is available for use by other U.S. government agencies and by academic and private institutions, providing access to the permanent microgravity setting, vantage point in low Earth orbit, and varied environments of space.
Media Contact: Patrick O'Neill
SOURCE Center for the Advancement of Science in Space
The best way to leverage your Cloud Expo presence as a sponsor and exhibitor is to plan your news announcements around our events. The press covering Cloud Expo and @ThingsExpo will have access to these releases and will amplify your news announcements. More than two dozen Cloud companies either set deals at our shows or have announced their mergers and acquisitions at Cloud Expo. Product announcements during our show provide your company with the most reach through our targeted audiences.
Feb. 21, 2017 01:15 PM EST Reads: 1,359
Cloud Expo, Inc. has announced today that Andi Mann and Aruna Ravichandran have been named Co-Chairs of @DevOpsSummit at Cloud Expo 2017. The @DevOpsSummit at Cloud Expo New York will take place on June 6-8, 2017, at the Javits Center in New York City, New York, and @DevOpsSummit at Cloud Expo Silicon Valley will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Feb. 21, 2017 01:15 PM EST Reads: 1,152
SYS-CON Events announced today that Outlyer, a monitoring service for DevOps and operations teams, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Outlyer is a monitoring service for DevOps and Operations teams running Cloud, SaaS, Microservices and IoT deployments. Designed for today's dynamic environments that need beyond cloud-scale monitoring, we make monitoring effortless so you...
Feb. 21, 2017 01:15 PM EST Reads: 1,189
DevOps is being widely accepted (if not fully adopted) as essential in enterprise IT. But as Enterprise DevOps gains maturity, expands scope, and increases velocity, the need for data-driven decisions across teams becomes more acute. DevOps teams in any modern business must wrangle the ‘digital exhaust’ from the delivery toolchain, "pervasive" and "cognitive" computing, APIs and services, mobile devices and applications, the Internet of Things, and now even blockchain.
Feb. 21, 2017 12:45 PM EST Reads: 720
WebRTC is the future of browser-to-browser communications, and continues to make inroads into the traditional, difficult, plug-in web communications world. The 6th WebRTC Summit continues our tradition of delivering the latest and greatest presentations within the world of WebRTC. Topics include voice calling, video chat, P2P file sharing, and use cases that have already leveraged the power and convenience of WebRTC.
Feb. 21, 2017 12:45 PM EST Reads: 640
Security, data privacy, reliability and regulatory compliance are critical factors when evaluating whether to move business applications from in-house client hosted environments to a cloud platform. In her session at 18th Cloud Expo, Vandana Viswanathan, Associate Director at Cognizant, In this session, will provide an orientation to the five stages required to implement a cloud hosted solution validation strategy.
Feb. 21, 2017 12:45 PM EST Reads: 4,482
Cloud Expo, Inc. has announced today that Aruna Ravichandran, vice president of DevOps Product and Solutions Marketing at CA Technologies, has been named co-conference chair of DevOps at Cloud Expo 2017. The @DevOpsSummit at Cloud Expo New York will take place on June 6-8, 2017, at the Javits Center in New York City, New York, and @DevOpsSummit at Cloud Expo Silicon Valley will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Feb. 21, 2017 12:30 PM EST Reads: 1,115
With 10 simultaneous tracks, keynotes, general sessions and targeted breakout classes, Cloud Expo and @ThingsExpo are two of the most important technology events of the year. Since its launch over eight years ago, Cloud Expo and @ThingsExpo have presented a rock star faculty as well as showcased hundreds of sponsors and exhibitors! In this blog post, I provide 7 tips on how, as part of our world-class faculty, you can deliver one of the most popular sessions at our events. But before reading the...
Feb. 21, 2017 12:30 PM EST Reads: 7,947
A strange thing is happening along the way to the Internet of Things, namely far too many devices to work with and manage. It has become clear that we'll need much higher efficiency user experiences that can allow us to more easily and scalably work with the thousands of devices that will soon be in each of our lives. Enter the conversational interface revolution, combining bots we can literally talk with, gesture to, and even direct with our thoughts, with embedded artificial intelligence, whic...
Feb. 21, 2017 12:30 PM EST Reads: 542
20th Cloud Expo, taking place June 6-8, 2017, at the Javits Center in New York City, NY, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy.
Feb. 21, 2017 12:15 PM EST Reads: 1,320
Feb. 21, 2017 11:45 AM EST Reads: 1,889
Bert Loomis was a visionary. This general session will highlight how Bert Loomis and people like him inspire us to build great things with small inventions. In their general session at 19th Cloud Expo, Harold Hannon, Architect at IBM Bluemix, and Michael O'Neill, Strategic Business Development at Nvidia, discussed the accelerating pace of AI development and how IBM Cloud and NVIDIA are partnering to bring AI capabilities to "every day," on-demand. They also reviewed two "free infrastructure" pr...
Feb. 21, 2017 11:45 AM EST Reads: 354
Have you ever noticed how some IT people seem to lead successful, rewarding, and satisfying lives and careers, while others struggle? IT author and speaker Don Crawley uncovered the five principles that successful IT people use to build satisfying lives and careers and he shares them in this fast-paced, thought-provoking webinar. You'll learn the importance of striking a balance with technical skills and people skills, challenge your pre-existing ideas about IT customer service, and gain new in...
Feb. 21, 2017 11:45 AM EST Reads: 1,979
TechTarget storage websites are the best online information resource for news, tips and expert advice for the storage, backup and disaster recovery markets. By creating abundant, high-quality editorial content across more than 140 highly targeted technology-specific websites, TechTarget attracts and nurtures communities of technology buyers researching their companies' information technology needs. By understanding these buyers' content consumption behaviors, TechTarget creates the purchase inte...
Feb. 21, 2017 11:30 AM EST Reads: 1,090
Feb. 21, 2017 11:30 AM EST Reads: 5,109